BioNTech AG Enters into Licensing Agreement with CELLSCRIPT, LLC as it Advances Development of Messenger RNA Encoding Bispecific Antibodies and other Therapeutic Proteins
06 sept. 2017 02h00 HE
|
BioNTech AG
MAINZ, Germany, Sept. 06, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that it has entered into a...
Nature Publication Reports Favorable Clinical Trial Results of BioNTech's Individualized Cancer Vaccine IVAC® MUTANOME
05 juil. 2017 13h01 HE
|
BioNTech AG
MAINZ, Germany, July 05, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced Phase I trial results...
Nature Medicine Reports Elimination of Large Tumors in Mice by Messenger RNA-Encoded Bispecific Antibodies
12 juin 2017 11h01 HE
|
BioNTech AG
MAINZ, Germany, June 12, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, reported preclinical data featuring a novel...
NATURE MEDICINE BERICHTET ÜBER ELIMINIERUNG GROßER TUMORE BEI MÄUSEN DURCH MESSENGER-RNA, DIE FÜR BISPEZIFISCHE ANTIKÖRPER KODIERT
12 juin 2017 11h01 HE
|
BioNTech AG
Mainz, June 12, 2017 (GLOBE NEWSWIRE) -- Die BioNTech AG, ein vollintegriertes Biotechnologieunternehmen, das personalisierte Krebsimmuntherapien entwickelt, gab heute präklinische Daten zu einer...
Nature Medicine Reports Elimination of Large Tumors in Mice by Messenger RNA-Encoded Bispecific Antibodies
12 juin 2017 11h01 HE
|
BioNTech AG
MAINZ, Germany, June 12, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, reported preclinical data featuring a novel...
BioNTech to Present Interim Phase I/II Data for Investigational mRNA Vaccine in Melanoma Patients at AACR Annual Meeting 2017
07 mars 2017 04h00 HE
|
BioNTech AG
MAINZ, Germany, March 07, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that it will present interim...
BioNTech to Present at Cowen and Company’s 37th Annual Health Care Conference
22 févr. 2017 02h00 HE
|
BioNTech AG
MAINZ, Germany, Feb. 22, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that Sean Marett, COO of...
BioNTech to Present at 35th Annual J.P. Morgan Healthcare Conference 2017
22 déc. 2016 02h00 HE
|
BioNTech AG
MAINZ, Germany, Dec. 22, 2016 (GLOBE NEWSWIRE) -- BioNTech AG, a fully integrated biotechnology company developing truly individualized cancer immunotherapies, today announced that Sean Marett, COO...